Inactive Instrument

Company diaDexus, Inc. OTC Bulletin Board

DDXS

US25245P1066

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- ^USD	-

21-09-17	Diadexus, Inc. Went Out of Business	CI
18-06-08	Motion for Asset Sale Approved for Diadexus, Inc.	CI

Business description: diaDexus, Inc.

Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Company details: diaDexus, Inc.

Diadexus, Inc.

349 Oyster Point Boulevard

94080-1913, South San Francisco

http://www.diadexus.com

Diagnostic & Testing Substances Manufacturers

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAREPTA THERAPEUTICS, INC.	+0.70%	-6.65%	+2.40%	-84.79%	1.97B
ULTRAGENYX PHARMACEUTICAL INC.	-0.62%	-1.64%	-50.45%	-59.03%	1.43B
BIONOTE, INC.	+0.32%	+0.11%	-20.21%	-3.12%	345M
DK LIFE SCIENCE CO., LTD.	+22.32%	+47.63%	-15.64%	-	65.97M
Average	+5.68%	+10.13%	-20.97%	-48.98%	952.13M
Weighted average by Cap.	+0.55%	-2.90%	-19.74%	-67.44%